سعر انسوليناجيبت ار 100 وحدة/مل 10 مل فيال 2025

• To improve glycemic control in adult and pediatric patients with diabetes mellitus.Population: Adults and pediatric patientsDailyMed (U.S. National Library of Medicine)

• Adverse reactions include hypoglycemia (most common), hypersensitivity reactions including anaphylaxis, hypokalemia, and injection-site lipodystrophy or localized cutaneous amyloidosis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to the product or any of its excipients.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Never share needles, syringes or pens between patients (risk of blood-borne pathogen transmission).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Changes in insulin regimen (strength, manufacturer, type, injection site or method) may cause hyper- or hypoglycemia; repeated injection into lipodystrophic or amyloid areas may cause hyperglycemia and a sudden change to an unaffected site may cause hypoglycemia. Make changes under close medical supervision with more frequent glucose monitoring.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypoglycemia is the most common adverse reaction of insulins and may be severe (seizures, unconsciousness, death); it can impair concentration and reaction time (e.g. driving).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Drugs that may increase hypoglycemia risk (antidiabetic agents, ACE inhibitors, ARBs, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues, sulfonamide antibiotics)May increase the risk of hypoglycemia; dose adjustment and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)
• Drugs that may decrease the glucose-lowering effect (e.g. atypical antipsychotics such as olanzapine and clozapine, corticosteroids, danazol, diuretics, estrogens)May reduce the blood-glucose-lowering effect; dose adjustment and more frequent glucose monitoring may be required.DailyMed (U.S. National Library of Medicine)

• Published data over decades have not established an association between human insulin use in pregnancy and major birth defects, miscarriage or adverse maternal or fetal outcomes; poorly controlled diabetes carries maternal and fetal risks.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Exogenous human insulin is transferred into human milk; no adverse reactions in breastfed infants have been reported; no data on effects on milk production.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.